By Jacob Bunge in Chicago and Christopher Alessi in Frankfurt
Bayer AG has pledged to add U.S. jobs and investment after meeting with President-elect Donald Trump, the latest in a string of public displays from companies looking to head off criticism from the incoming administration about job losses.
The German chemical conglomerate, which is seeking regulatory approval for its planned $57 billion purchase of biotech seed maker Monsanto Co., said Tuesday it would step up research investments and create "several thousand" new high-tech positions in the U.S. after completing the deal targeted to close by the end of the year.
The pledge came hours after General Motors Co. separately confirmed a plan to invest a further $1 billion in its U.S. manufacturing operations, and Hyundai Motor Co. outlined a new $3.1 billion investment in existing U.S. manufacturing plants. Also on Tuesday, Wal-Mart Stores Inc. touted its previous plans to add about 10,000 U.S. jobs this year, following online retailer Amazon.com Inc.'s announcement last week of an additional 100,000 full-time U.S. jobs, mostly through expansion plans already in the works.
According to Trump transition team spokesman Sean Spicer, Bayer's decision was the result of "the president-elect's focus on creating a better business climate here in the United States."
Mr. Spicer's comments, made to reporters on a conference call Tuesday, could leave Bayer and Monsanto little room to deviate from the employment commitment.
Companies large and smaller are pondering their prospects under Mr. Trump, who is set for inauguration Friday, and has wasted little time since his November election spotlighting companies he sees shirking their responsibility to the U.S. market and workers.
Following a campaign that emphasized job creation and domestic business expansion, Mr. Trump vowed to bring back manufacturing positions to the U.S., and since his election has castigated companies for shifting operations abroad while praising others for domestic expansion plans.
That has presented companies with the choice to strike a deal with Mr. Trump's team -- as Carrier Corp. did in November, keeping about 1,000 jobs in Indiana in return for new government incentives -- or reverse plans to shift some manufacturing abroad like Ford Motor Co. did recently. Others are opting to lie low, hoping to stay clear of the incoming president's Twitter feed. Wal-Mart's jobs plan, which derives from previously planned store expansions and openings and new e-commerce services, suggests that even the country's largest private employer feels the need to tout American job growth.
Concern over whether Bayer's planned takeover of Monsanto could hurt U.S. farmers' competitiveness was one factor behind a meeting in New York last week between Mr. Trump and Bayer Chief Executive Werner Baumann and Monsanto CEO Hugh Grant.
Some farmers and state officials on a committee created to advise the Trump campaign on farm policy this month called on the president-elect to block tie-ups between some of the agricultural industry's biggest players, saying competition will slacken and prices for seeds and crop sprays will rise.
Besides Bayer's Monsanto deal, which would create the world's No. 1 supplier by sales of both seeds and pesticides, Dow Chemical Co. and DuPont Co. are pursuing a merger that would create another agricultural giant, while China National Chemical Corp. plans to buy Swiss pesticide maker Syngenta AG.
Bayer said Tuesday it aims to invest over the next six years about $16 billion to research new crop seeds and pesticides, with half that spending planned for the U.S., while adding several thousand new high-tech positions in the U.S.
Mr. Spicer went further, telling reporters Tuesday that Bayer's Mr. Baumann pledged to keep all of Monsanto's more than 9,000 U.S. jobs in the country and to create at least 3,000 new U.S. high-tech jobs.
A Bayer spokesman declined to elaborate on specific numbers.
While Bayer has said its deal for Monsanto isn't based on cutting costs from the combined businesses, the German company has targeted about $1.5 billion in cost savings from the deal. On a September conference call with employees, Mr. Baumann acknowledged that some layoffs could be inevitable due to overlapping jobs.
Bayer's Tuesday commitment on R&D spending works out to a total of about $2.7 billion a year, which isn't far from what the companies already spend. Monsanto spent slightly more than $1.5 billion on research and development efforts in each of the past two years, while Bayer spent about $1 billion in agricultural R&D in 2014 and $1.17 billion in 2015.
"The United States is a global leader in agriculture, and the combination of Bayer-Monsanto will underscore that role and ensure the United States retains a pre-eminent position as the anchor of the industry," Bayer and Monsanto said in a joint statement following Mr. Spicer's comments.
While Mr. Trump's critiques of megamergers like AT&T Inc.'s planned takeover of Time Warner Inc. have fueled investor concern that he could take aim at other big deals, antitrust lawyers said that questions of lost jobs -- and pledges to keep them -- typically don't factor into the nitty-gritty of deal reviews.
"This kind of environment on the outside is, to the [antitrust] agencies, very unhealthy," said Bill Kovacic, professor of competition law at George Washington University and former chairman of the Federal Trade Commission. "It creates the impression that the competition agencies are a direct extension of the political process."
Write to Christopher Alessi at firstname.lastname@example.org and Jacob Bunge at email@example.com
(END) Dow Jones Newswires
January 18, 2017 02:48 ET (07:48 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.